View Older Stories

Apr 3, 2025 08:00AM Phathom Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

Aug 19, 2024 08:01AM Phathom Pharmaceuticals Inc. (PHAT) Prices $130M Share and Warrant Offering at $11.50/sh

Aug 19, 2024 08:00AM Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants

Apr 5, 2024 01:00PM M&A watch: 3 biotech companies that are most likely to be acquired - Needham

Apr 3, 2024 08:00AM Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Jun 9, 2023 04:01PM Phathom Pharmaceuticals Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock

May 24, 2023 05:42AM Phathom Pharmaceuticals (PHAT) Prices 11.13M Share Offering at $11.75/sh

May 23, 2023 07:41PM Phathom Pharmaceuticals Announces Pricing of Public Offering of Common Stock

May 23, 2023 04:01PM Phathom Pharmaceuticals Inc. (PHAT) Announces Proposed Stock Offering

May 23, 2023 04:01PM Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock

Apr 12, 2023 08:00AM Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

Apr 12, 2023 08:00AM Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

May 25, 2022 11:33AM Phathom Pharmaceuticals (PHAT) PT Lowered to $44 at Needham & Company to Reflect vonoprazan Launch Dynamic, "Remain Confident in the Commercial Potential"

May 4, 2022 07:22AM Needham & Company Reiterates Buy Rating, $55 Price Target on Phathom Pharmaceuticals (PHAT) Following Voquezna Approval

Apr 1, 2022 08:01AM Phathom Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference

Apr 1, 2022 08:01AM Phathom Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference

Mar 2, 2022 06:34AM Needham & Company Reiterates Phathom Pharmaceuticals (PHAT) at Buy, Expects Approval of vonoprazan for H.pylori, Sees It as Laying Groundwork for Potential Approval in EE

Oct 26, 2021 04:01PM Phathom Pharmaceuticals Inc. (PHAT) Announces Proposed 5M Share Stock Offering

Oct 26, 2021 04:01PM Phathom Pharmaceuticals Announces Proposed Public Offering of 5,000,000 Shares of Common Stock

Oct 26, 2021 04:01PM Phathom Pharmaceuticals Announces Proposed Public Offering of 5,000,000 Shares of Common Stock

Apr 6, 2021 08:00AM Phathom Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference

Apr 6, 2021 08:00AM Phathom Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference

Dec 17, 2020 06:14AM Phathom Pharmaceuticals Inc. (PHAT) Prices 2.25M Share Common Offering at $42/Sh

Dec 16, 2020 06:43PM Phathom Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Dec 16, 2020 06:43PM Phathom Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Dec 15, 2020 04:02PM Phathom Pharmaceuticals Inc. (PHAT) Announces Proposed 2.5M Common Share Offering

Dec 15, 2020 04:01PM Phathom Pharmaceuticals Announces Proposed Public Offering of 2,250,000 Shares of Common Stock

Dec 15, 2020 04:01PM Phathom Pharmaceuticals Announces Proposed Public Offering of 2,250,000 Shares of Common Stock

Dec 15, 2020 08:42AM Phathom Pharmaceuticals (PHAT) PT Raised to $55 at Needham & Company

Apr 9, 2020 04:30PM Phathom to Participate at the 19th Annual Needham Virtual Healthcare Conference

Apr 9, 2020 04:30PM Phathom to Participate at the 19th Annual Needham Virtual Healthcare Conference

Nov 19, 2019 07:45AM Needham & Company Starts Phathom Pharmaceuticals (PHAT) at Buy, Street High $40 PT

Oct 29, 2019 04:05PM Phathom Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Oct 25, 2019 12:03PM Phathom Pharmaceuticals (PHAT) IPO Opens 18% Higher

Oct 25, 2019 05:53AM Phathom Pharmaceuticals, Inc. (PHAT) Prices 9.56M Share IPO at $19/Sh

Oct 24, 2019 08:25PM Phathom Pharmaceuticals Announces Pricing of Initial Public Offering

View Older Stories